Ketorolac in Palatoplasty: A Randomized Blinded Controlled Trial.
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 4
SUMMARY
The purpose of this study is to see if the addition of IV Ketorolac to usual care multi-modal pain therapy compared to usual care will improve oral intake post-operatively
Eligibility
Participation Requirements
Sex: All
Minimum Age: 6 months
Healthy Volunteers: f
View:
• Patient with Cleft palate (Complete and incomplete), with or without cleft lip, unilateral or bilateral
Locations
United States
Texas
The University of Texas Health Science Center at Houston
RECRUITING
Houston
Contact Information
Primary
Matthew R Greives, MD,MS,FACS
Matthew.R.Greives@uth.tmc.edu
(713) 500-7275
Backup
Alfredo Cepeda Jr., MD
Alfredo.Cepeda@uth.tmc.edu
(713) 500-7216
Time Frame
Start Date: 2021-09-17
Estimated Completion Date: 2026-01-31
Participants
Target number of participants: 74
Treatments
Experimental: Experimental group (Ketorolac)
Placebo_comparator: Control Group
Related Therapeutic Areas
Sponsors
Leads: The University of Texas Health Science Center, Houston